Estraderm TTS

 

Topic mentions per year

Topic mentions per year

1992-2001
02419922001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
OBJECTIVES to compare the patterns of a 17 beta-estradiol (E(2)) gel containing 0.6 mg/g (1.5 mg E(2) per day, Gelestra); with… (More)
Is this relevant?
1997
1997
OBJECTIVE To compare the local tolerability and adhesion of two transdermal systems for estradiol delivery, an established… (More)
Is this relevant?
1996
1996
OBJECTIVES The objectives were to compare the local skin tolerability of a matrix-type estradiol transdermal system, Oesclim 50… (More)
Is this relevant?
1996
1996
OBJECTIVES The objectives were to compare the tolerability, adhesion and efficacy of a new matrix-type estradiol transdermal… (More)
Is this relevant?
1996
1996
To further study the mechanism of the antigonadotropic activity of progestins, the effects of a 19-nortestosterone derivative… (More)
Is this relevant?
1995
1995
OBJECTIVE To determine the efficacy of a 100 micrograms twice weekly dose of Estraderm TTS compared with a 200 micrograms dose in… (More)
Is this relevant?
1995
1995
Two-hundred and five (205) menopausal women with moderate to severe vasomotor symptoms, aged 39-64 years, were randomized from 20… (More)
Is this relevant?
1994
1994
In 20 patients with pure menstrual migraine either Estraderm TTS 50 patches (E) or placebo (P) patches were applied during three… (More)
Is this relevant?
1992
1992
To prevent hyperplasia and carcinoma of the endometrium during Estrogen Replacement Therapy (ERT), addition of progestogens once… (More)
Is this relevant?
1992
1992
In an open-label, multicentric randomized trial the efficacy and tolerability of Estraderm TTS, a 17 beta-estradiol, and Premarin… (More)
Is this relevant?